TY  - CONF

T1  - UPDATED SURVIVAL, QUALITY OF LIFE (QOL), AND SAFETY DATA OF RADIUM-223 CHLORIDE (RA-223) IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASES FROM THE PHASE 3 DOUBLE-BLIND, RANDOMIZED, MULTINATIONAL STUDY (ALSYMPCA)

JO  - ANNALS OF ONCOLOGY

PY  - 2012/09/01

AU  - Parker C

AU  - Coleman RE

AU  - Nilsson S

AU  - Vogelzang N

AU  - Lloyd AJ

AU  - Staudacher K

AU  - van Gool R

AU  - Sartor AO

ED  - 

VL  - 23

SP  - 296

EP  - 296

Y2  - 2025/10/10

ER  -